Independent. No paid placement. Reviewed weekly Editorial policy Newsletter

Home›The Library›Oxytocin

Oxytocin

Written by The Peptide Record editorialClinical review not yet completedLast reviewed 12 September 2026

Yes, as Pitocin, it's a genuine, long-approved drug for inducing and augmenting labor and controlling postpartum bleeding. No, the "trust hormone" nasal-spray marketing for bonding, libido or social connection isn't backed by the trial evidence — the largest controlled human trial of intranasal oxytocin for a social/behavioral outcome found no significant benefit on its primary measure.

On this page
  1. What it's actually approved for
  2. The "trust hormone" marketing, and what its trials show
  3. The gap between the approved and marketed uses
  4. Safety notes

In brief

Should you care? Yes if you've seen oxytocin nasal spray marketed for bonding or libido — its one real controlled trial for a social/behavioral outcome found no benefit.

The short version

  • Genuinely approved, as Pitocin, for labor induction/augmentation and postpartum bleeding control.
  • The largest controlled trial of intranasal oxytocin for a behavioral outcome (autism) found no significant effect.
  • The wellness nasal-spray marketing has no relationship to the approved obstetric use.

What it's actually approved for

Oxytocin (Pitocin) is FDA-approved for induction or augmentation of labor with a medical indication, to produce uterine contractions that control postpartum bleeding, and as adjunctive therapy in incomplete or inevitable abortion — a long-established obstetric drug with decades of use in that specific setting.

The "trust hormone" marketing, and what its trials show

Intranasal oxytocin has real published research behind effects like improved eye gaze, emotion recognition and trust in some laboratory settings in neurotypical adults. But the largest, best-controlled human trial testing a genuine clinical hypothesis — a 24-week, multisite, placebo-controlled trial in 277 children and adolescents with autism spectrum disorder (Sikich et al., N Engl J Med 2021;385(16):1462-1473, PMID 34644471) — found no significant effect of oxytocin on its primary measures of social and cognitive functioning. That's directly comparable to how this site treats ipamorelin's bowel-recovery trial or thymosin alpha-1's sepsis trial: a real, adequately sized, controlled trial that didn't find what proponents claimed.

The gap between the approved and marketed uses

The nasal-spray "bonding," libido and cosmetic-wellness products bear no relationship to Pitocin's approved obstetric indication, dose or monitored clinical setting — worth stating explicitly rather than letting the drug's real approval lend credibility to an unrelated marketed use.

Safety notes

Pitocin carries real, well-documented risks in its approved obstetric context, including uterine hyperstimulation and water intoxication at high doses — risks specific to that clinical setting and dose, not necessarily the same as whatever risk profile applies to low-dose intranasal use.

References

  1. Pitocin FDA-approved labeling, accessdata.fda.gov.
  2. Sikich et al., "Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder," N Engl J Med 2021;385(16):1462-1473, PMID 34644471.